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To understand whether hypoxia-inducible factor 1-alpha (HIF-1α) could protect AtT-20 cells from 
hypoxia induced apoptosis, we investigated the effects of HIF-1α on proliferation and apoptosis of 
adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma cells (AtT-20 cells). AtT-20 cells were 
treated with various concentrations of CoCl2 to induce hypoxia. 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, a yellow tetrazole (MTT) was applied to detect the proliferation of these 
cells. Western blot assay and real time polymerase chain reaction (PCR) were used to determine the 
protein and mRNA expressions of HIF-1α, respectively. In addition, AtT-20 cells were transfected with 
siRNA targeting HIF-1α and treated with different concentrations of CoCl2. The transfection efficacy was 
assessed by real-time PCR and western blot assay. Apoptosis was measured by fluorescein 
isothiocyanate (FITC)-annexin V/ propidium iodide (PI) staining and TUNEL staining. The effect of CoCl2 
on the proliferation of AtT-20 cells was in a concentration and time dependent manner. When the 
concentration of CoCl2 was ≤100 µM and/or duration of CoCl2 treatment was ≤48 h, CoCl2 triggered the 
proliferation of AtT-20 cells. Nevertheless, the apoptosis rate of cells transfected with HIF-1α-siRNA was 
markedly increased after CoCl2 treatment. These findings suggest that, HIF-1α can promote the 
proliferation of AtT-20 cells and exert anti-apoptotic effect under hypoxic condition.  
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INTRODUCTION   
 
Oxygen is indispensable for the growth of solid tumor and 
it is also true in pituitary adenoma (Shannon et al., 2003). 
Kristof et al. (2003) demonstrated that the oxygen partial 
pressure in pituitary adenoma is significantly lower than 
in the normal pituitary tissues. Hypoxia may promote the 
apoptosis of tumor cells. However, necrotic or apoptotic 
cells are seldom found in pituitary adenoma. We spe-
culate that certain factors probably facilitate the tolerance 
of pituitary adenoma to hypoxia. The expression and 
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for the hypoxic accommodation. Our previous study 
showed HIF-1α and vascular endothelial growth factor 
(VEGF), a marker of angiogenesis, which were expres-
sed in different types of pituitary adenoma and their 
expression levels were positively associated with the 
invasive property of pituitary adenoma, although, there 
was no relationship between the expressions of HIF-1α 
and VEGF (Zhang et al., 2008). Therefore, HIF-1α may 
affect the occurrence and development of pituitary 
adenoma in a VEGF independent way. In the present 
study, different concentrations of cobalt chloride (CoCl2) 
were employed to induce a hypoxic environment in adre-
nocorticotropic hormone-secreting pituitary adenoma cell 
line (AtT-20 cells) and western blot and real time 





the protein and mRNA expressions of HIF-1α. Then, AtT-
20 cells were transfected with siRNA targeting HIF-1α 
followed by determination of apoptosis of AtT-20 cells by 
fluorescein isothiocyanate (FITC)-Annexin V/PI staining 
and TdT-mediated dUTP-biotin nick end labeling 
(TUNEL) staining, which further confirmed the role of HIF-




MATERIALS AND METHODS 
 
Cell culture and CoCl2 treatment  
 
Mouse AtT-20 cells were kindly provided by Prof. Ning G and Prof. 
Li XY of Shanghai Institute of Endocrine and Metabolic Diseases. 
AtT-20 cells have the characteristic of suspended growth and the 
medium was refreshed every 1 to 2 days. Passaging was perfor-
med every 3 to 4 days through centrifugation. Cells were seeded in 
6-well plate and incubated with different concentrations (0.25, 50, 
100 and 200 µM) of CoCl2 in a humidified atmosphere of 95% air 





3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a 
yellow tetrazole (MTT), dimethyl sulfoxide (DMSO) (Sigma-Aldrich, 
USA), TRIzol (Invitrogen, USA), SYBR®Premix Ex Taq, PCR kit 
(TaKaRa, Japan), rabbit anti-mouse HIF-1α polyclonal antibody, 
mouse specific HIF-1α-siRNA and mock siRNA (Sigma-Aldrich, 
USA), Annexin V-FITC apoptosis detection kit (BD, USA) and 
TUNEL assay kit (Boehringer Mannheim, Germany) were used in 
the present study.  
 
 
Detection of proliferation by MTT assay 
 
Cells were seeded in a 96-well plate at a density of 1×10
3
 cells/ml 
followed by incubation with different concentrations of CoCl2 at 
37°C for 24 h. Then, 20 µl of MTT solution (5 mg/ml) were added to 
each well followed by incubation for another 4 h. Centrifugation was 
performed at 2500 rpm for 10 min and the supernatant was 
removed. The sediment was suspended in 150 µl of DMSO and 
stirred in a Vortex mixer for 10 min. The optical density (OD) was 
measured at 540 nm with a microplate reader.    
 
 
Extraction of total RNA and real time PCR 
 
Total RNA was extracted with TRIzol and reverse transcription was 
carried out in a mixture containing 1 µg of total RNA, 1 µl of 
oligo(dT)15 primers and diethylpyrocarbonate (DEPC) treated water 
at 70°C for 5 min. Then, the mixture was kept on ice for 5 min and 
mixed with 5 µl of M-MLV RT 5× buffer, 0.5 µl of 100 mM dNTP, 1 µl 
of M-MLV and DEPC treated water (total volume: 15 µl) followed by 
reaction at 40°C for 60 min and then 70°C for 15 min. Real time 
PCR was performed in 20 µl of mixture with the SYBR®Premix Ex 
Taq(perfect real time) PCR kit. The conditions for PCR included a 
pre-denaturation at 95°C for 10 s and 40 cycles of denaturation at 
95°C for 5 s, annealing at 60°C for 31 s. Melt curve was delineated 
according to the copy number at 65 to 95°C. Data were analyzed 
with applied biosystems7300 SDS software. 2
-∆∆CT
 was used to 
calculate the initial copies followed by plotting and statistical 
analysis. The primers were designed based on the Primer Bank and 
synthesized   in   Shanghai   Invitrogen.   The  anticipated  length  of  




products was 228 bp and the primers were as follows: HIF-1α: 
forward: 5’-ACCTTCATCGGAAACTCCAAAG-3; reverse: 5’-CTG 
TTAGGCTGGGAAAAGTTAGG-3’; β-actin: forward: 5’-GGCTG 




Western blot assay   
 
Total protein was extracted and protein concentration was 
measured with a bicinchoninic acid (BCA) protein assay kit with 
Bradford method. Then, 100 µg of protein were subjected to sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
and transferred to polyvinylidene fluoride (PVDF) membrane 
followed by blocking in 10% non-fat milk at room temperature for 2 
h. The membrane was incubated with rabbit anti-mouse HIF-1α 
polyclonal antibody (1:500) at 4°C overnight followed by 3 washes 
in 1× TBST. The membrane was treated with horseradish 
peroxidase conjugated secondary antibody in TBS containing 5% 
non-fat milk at room temperature for 1 h. After 3 washes in 1× 




Transfection with siRNA 
 
Cells were suspended in antibiotics free medium and 4×10
5
 cells 
were seeded in a 12-well plate flowed by incubation at 37°C in a 
humidified atmosphere of 5% CO2 and 95% air for 5 h. When cell 
confluence reached 90%, these cells were transfected with siRNA 
targeting HIF-1α. Briefly, 4 µl of 10 µM HIF-1α-siRNA were mixed 
with 2 µl of lipofectamine 2000 and 100 µl of OPTI-MEM achieving 
solution A and B, respectively, followed by incubating at room 
temperature for 5 min. Then, solution A was added to solution B 
followed by incubation at room temperature for 20 min. The mixture 
containing solution A and B was added to each well followed by 
incubation for 24 h. Subsequently, these cells were maintained in 
antibiotics containing medium and treated with CoCl2 to induce 
hypoxia. The trasnfection efficacy was determined by real time PCR 
and western blot assay. In addition, cells transfected with mock 
siRNA served as control and received similar treatment.  
 
 
Annexin V-FITC staining and TUNEL staining  
 
AtT-20 cells were divided into 4 groups: Group A: normoxia group 
(control); Group B: CoCl2 treatment group; Group C: CoCl2 
treatment plus HIF-1α-siRNA transfection group; Group D: CoCl2 
treatment plus mock siRNA transfection group. Experiment was 





Comparisons of OD values and initial copy number were performed 
with two-tailed t test. Data were expressed as means ± standard 






Effect of CoCl2 on AtT-20 proliferation in a time and 
concentration dependent manner 
 
After treatment with different concentrations (0.25, 50, 
100 µM) of CoCl2 for 24 h, the proliferation of AtT-20 cells  








0 25 µM 50 µM 100 µM 100 µM+siRNA 100 µΜ+mock 
Day 1 0.356±0.012 0.629±0.015 0.721±0.010 0.826±0.008 0.409±0.003 0.774±0.011 
Day 2 0.235±0.015 0.655±0.023 0.740±0.006 0.843±0.007 0.375±0.005 0.824±0.006 




was markedly increased and positively related to the 
CoCl2 concentration (Table 1). The highest proliferation 
was observed at the concentration of 100 µM. However, 
treatment with 200 µM CoCl2 markedly inhibited the 
growth of AtT-20 cells (Figure 1a). So, 100 µM was used 
as an optimal concentration and treatment was prolonged 
(a maximum of 3 days) (Figure 1b). But the growth of 
AtT-20 cells was also significantly suppressed (P < 0.05), 
which may be related to the toxicity of CoCl2. In addition, 
after transfection with HIF-1α-siRNA, cell proliferation 
was decreased.  
 
 
mRNA and protein expressions of HIF-1α  
 
After treatment with different concentrations of CoCl2 for 
24 h, real time PCR and western blot assay were em-
ployed to measure the mRNA (Figure 2a) and protein 
(Figure 2b) expressions, respectively. As shown in Figure 
2, expressions of HIF-1α were detectable in AtT-20 cells 
under both nomoxic and hypoxic conditions, but AtT-20 
cells had relatively low expressions of HIF-1α under 
nomoxic condition. The mRNA and protein expressions of 
HIF-1α were increased with the increase in CoCl2 
concentration, which suggests that CoCl2 treatment can 
induce hypoxia. When the CoCl2 concentration was 100 
µM, the expressions of HIF-1α reached maximal levels. 
These results were consistent with those in MTT assay.  
 
 
Transfection efficacy of HIF-1α-siRNA  
 
AtT-20 cells were divided into 6 groups: Group A: 
normoxia (control); Group B: normoxia plus mock siRNA 
transfection; Group C: CoCl2 treatment; Group D: CoCl2 
treatment plus HIF-1α-siRNA transfection; Group E: 
CoCl2 treatment plus mock siRNA transfection; Group F: 
AtT-20 cells were incubated in a hypoxia incubator for 24 
h. After treatment, real time PCR and western blot assay 
were performed to measure the mRNA and protein 
expression of HIF-1α to determine the transfection 
efficacy. As shown in Figure 3a, the mRNA expression 
was down-regulated by >50% (P < 0.05), but not 
markedly changed in the mock siRNA transfection group. 
Similar trend was also found in the protein expression 
(Figure 3b). Moreover, our results showed that, 
incubation in a hypoxia incubator (physical hypoxia) could 
also generate similar consequence to that after CoCl2 
treatment (chemical hypoxia).  
 
 
Apoptosis of AtT-20 cells 
 
FITC-annexin V/PI staining was used to detect the early 
apoptosis and results showed that, the apoptosis rate 
was about 10% in CoCL2 (100 µM) treatment group and 
CoCL2 (100 µM) treatment plus mock siRNA group. 
However, transfection with HIF-1α-siRNA followed by 
CoCL2 treatment significantly increased the apoptosis 
rate (28.90%) (P < 0.05). In addition, TUNEL staining 
(Figure 4) showed that apoptotic cells were only noted in 
HIF-1α-siRNA transfection plus CoCL2 treatment group 
(Figure 4). These findings suggest that, HIF-1α can 
protect the AtT-20 cells against hypoxia induced 
apoptosis and plays an important role in the occurrence 





Sufficient blood supply is necessary for the growth of 
solid tumor and can maintain the essential homeostasis 
for cell survial. However, when the growth rate of tumor 
overwhelms that of angiogenesis, the comsumption of 
oxygen and nutrients significantly increases in tumors, 
resulting in a hypoxic, low glucose and acidic environ-
ment. It has been demonstrated that, hypoxia can elicit 
protective responses to stress. Angiogenesis and 
anaerobic metabolism are the prerequisites for tumor 
cells surving, growing and proliferating in a hypoxic 
environment. Among numerous factors, the expression 
and activity of HIF-1 play crucial roles in the hypoxia 
adaptation of cells. Through regulating gene expression, 
HIF-1 can promote angiogenesis, hematopoiesis and 
glycometabolism and may modulate apoptosis, cell cycle 
and other functions of cells. The pathophysiological 
effects of HIF-1 are essential for the adaptation of cells to 
hypoxia (Mabjeesh and Amir, 2007). Evidence shows 
that, activated HIF-1 can directly or indirectly increase the 
transcription of about 2% of genes in the human genome 
(Manalo et al., 2005).  
Kristof et al. (2003) reported that, the oxygen partial 
pressure in pituitary adenoma was significantly lower 
than  in   the  surrounding  normal  tissues.  Hypoxia  may  







Figure 1. MTT assay was used to detect the proliferation of AtT-20 
cells after treatment with different concentrations of CoCl2. The 
highest proliferation was observed at the concentration of 100 µM. 
But 200 µM CoCl2 resulted in death of a vast majority of AtT-20 cells 
(A). After treatment with CoCl2 (≤100 µM) for 1 to 3 days, the 
proliferation of AtT-20 cells was dramatically decreased (P < 0.05). 
Furthermore, AtT-20 cells transfected with HIF-1α-siRNA had 
pronounced decrease in proliferation (P < 0.05).  



















Figure 2. AtT-20 cells were treated with different concentrations of CoCl2 (0 to 
200 µM) for 24 h and real time PCR and western blot assay were employed to 
detect the mRNA (A) and protein (B) expressions of HIF-1α. Results showed 
AtT-20 cells had relatively low expressions of HIF-1α under normoxic condition 
and the expressions of HIF-1α elevated with the increase in CoCl2 
concentration. When the CoCl2 concentration was 100 µM, the mRNA and 
protein expression of HIF-1α reached a maximal level. After treatment with 100 




facilitate the apoptosis of tumor cells, but necrotic or 
apoptotic cells were seldom noted in pituitary adenoma. 
This finding implies that, HIF-1α may be involved in the 
angiogenesis and apoptosis of pituitary adenoma cells 
and plays a critical role in the occurrence and 
development of pituitary adenoma. Vidal et al.
 
(2003) 
applied immunohistochemistry to detect HIF-1α expres-
sion and results showed that, HIF-1α was expressed in a 
variety of pituitary adenomas. However, the biological role 
of HIF-1α in pituitary adenoma is still poorly understood. 
HIF-1α induced regulatory response can partially explain 
why the pituitary adenoma cells can survive in a hypoxic 
environment, but can not explain how these cells 
proliferate in the absence or insufficiency of nutrients. 
Escaping from hypoxia induced cell death may be a 
reasonable explanation.       
In the present study, CoCl2 treatment was conducted to 
mock a hypoxic  environment.  Our  results  showed  that,  
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Figure 3. Real-time PCR and western blot assay were employed to detect the transfection efficacy. 
As shown in A, the mRNA expression of HIF-1α was decreased by >50% after HIF-1α-siRNA 
transfection (P < 0.05), but not dramatically reduced after mock siRNA transfection. As shown in A, 
HIF-1α-siRNA transfection could also down-regulate the protein expression of HIF-1α. 
Furthermore, incubation in a hypoxia incubator for 24 h had similar effects on the HIF-1α 




treatment with CoCl2 of different concentrations (0.25, 50, 
100 µM) could promote the proliferation of AtT-20 cells, 
which was in a concentration denpendent manner. The 
highest proliferation was observed at a concentration of 
100 µM. In addition, 200 µM CoCl2 treatment or 
prolonged CoCl2 treatment (3 days) could signficantly 
decreased the growth of AtT-20 cells (P < 0.05). At the 
same time, AtT-20 cells were also incubated in a hypoxia 
incubator to mimic physical hypoxia the effect of which on 
cell proliferation was compared with that of CoCl2 
treatment serving as chemical hypoxia. Results showed 
that, incubation in a hypoxia incubator for 24 h could 
produce similar effect on cell proliferation to that after 
CoCl2 treatment at certain concentration for 24 h. More-
over, HIF-1α-siRNA transfection markedly decreased the 
proliferation of AtT-20 cells (Figure 1). After HIF-1α-
siRNA transfection followed by CoCl2 treatment, Annexin 
V-FITC staining and TUNEL staining (Figure 4) revealed 
the apoptosis rate was dramatically increased (P < 0.05). 
These findings suggest that,  HIF-1α  can  protect  mouse  
















Figure 4. Apoptosis of AtT-20 cells in different groups (TUNEL staining). Apoptotic 
cells were only observed in the HIF-1α-siRNA transfection plus CoCL2 treatment 





AtT-20 cells from hypoxia induced apoptosis and plays 
critical role in the occurrence and development of 
pituitary adenoma.    
Currently, the role of HIF-1α in apoptosis still remains 
controversial and conflict results have been reported 
(Achison and Hupp, 2003). Study showed that, hypoxia 
could up-regulate or stabilize proteins of Bcl-2 family to 
directly exert pro-apoptotic effect (Kothari et al., 2003; 
Iida et al., 2002; Koshiji et al., 2004; Harris et al., 2002; 





induce p53 expression, the p53 expression level is 
affected by hypoxic microenvironment (Pan et al., 2004). 
Several studies show that, HIF-1α can exert protective 
effect through suppressing hypoxia induced apoptosis 
(Akakura et al., 2001). Therefore, pancreatic cancer cells 
expressing HIF-1α are more tolerant to hypoxia induced 
apoptosis than similar cells without HIF-1α expression 
(Moritz et al., 2002). Evidence shows that, after neutrali-
zation of VEGF (a key downstream protein of HIF-1α) 
with monoclonal antibody, the anti-apoptotic effect of HIF-
1α is absent, which directly confirms the anti-apoptotic 
effect of HIF-1α
 
(Baek et al., 2000). Previous work also 
reported that, inhibitor of apoptosis protein 2 (IAP-2), an 
important anti-apoptotic protein, was also regulated by 
HIF-1α (Greijer and van der Wall, 2004). Yoshida et al. 
(2005) applied aicroarray analysis technique to detect 
genomic changes in human nonfunctioning pituitary 
adenoma cells (HP75 cells) after hypoxia. Their results 
did not reveal significant changes in expression of p53, 
Bcl-2 and IAP-2 family. These findings suggest that, the 
apoptosis related genes regulated by HIF-1α vary from 
different tumors. Based on the results of the present 
study, we speculate that HIF-1α plays an anti-apoptotic 
role in the occurrence and development of pituitary 
adenoma, but the exact biological mechanism should be 





HIF-1α, Hypoxia inducible factor-1; VEGF, vascular 
endothelial growth factor; FITC, fluorescein 
isothiocyanate; TUNEL, TdT-mediated dUTP-biotin nick 
end labeling; MTT, 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, a yellow tetrazole, DMSO, 
dimethyl sulfoxide; BCA, bicinchoninic acid; PVDF, 
polyvinylidene fluoride; SDS-PAGE, sodium dodecyl 
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